Novavax, Inc. company logo
Novavax, Inc. logo

Novavax, Inc. (NVAX) Cash From Financing

Annual CFF

$260.58M$252.53M+3,134.24%

Summary

Current Value
As of today, NVAX annual cash from financing is $260.58M, up +3134.24% on
Historical Performance
NVAX annual cash from financing is down -43.56% over the past 3 years, and up +164.86% over the past 5 years
All-Time High Comparison
NVAX annual cash from financing is currently -73.54% below its historical high of $984.76M set on
3-Year Low Comparison
NVAX annual cash from financing is +3134.24% above its 3-year low of $8.06M reached on
Sector Comparison
NVAX annual cash from financing is higher than 92.36% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

NVAX Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing$260.58M+3134.2%-43.6%+164.9%+516.1%
Quarterly Cash From Financing$42.44M+10000.0%+237.0%+289.6%+122.9%
TTM Cash From Financing$30.92M-91.5%-57.5%-94.9%-28.9%
Price$7.78-9.0%-36.7%-93.9%-84.5%
Annual Cash From Operations-$87.26M+87.8%-127.0%+36.1%-165.8%
Annual Cash From Investing-$204.04M-247.0%-303.7%-630.1%-8764.0%
Annual Dividends Paid$0.000.0%0.0%0.0%0.0%
Annual Total Debt$263.47M-6.1%-49.7%-20.6%+10000.0%
Shares Outstanding162.50M+1.3%+88.9%+129.0%

Cash From Financing Highs

NVAX Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y$324.99MN/A-19.8%
5Y$984.76MN/A-73.5%
All$984.76M-73.5%

Cash From Financing Lows

NVAX Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y$8.06M+3134.2%
5Y$8.06M+3134.2%
All-$720.00K>+9999.0%

Cash From Financing History

YearValueChange
$260.58M+3,134.2%
$8.06M-97.5%
$324.99M-29.6%
$461.71M-53.1%
$984.76M+900.9%
$98.38M-4.3%
$102.81M+59.3%
$64.54M-76.9%
$279.03M+34.0%
$208.28M+89.8%
$109.72M-16.3%
$131.04M+143.6%
$53.79M+383.3%
$11.13M-52.5%
$23.43M-44.6%
YearValueChange
$42.29M+148.9%
$16.99M+2,460.0%
-$720.00K-101.3%
$56.89M+184.6%
$19.99M-8.9%
$21.95M-50.2%
$44.09M+222.2%
$13.69M-11.2%
$15.41M-59.0%
$37.56M+797.0%
$4.19M+253.3%
$1.19M-77.9%
$5.35M+166.8%
$2.01M-82.2%
$11.29M-

FAQ

  • What is the current annual cash from financing of NVAX?

    As of today, NVAX annual cash from financing is $260.58M

  • What is 1-year change in NVAX annual cash from financing?

    NVAX annual cash from financing is up +3134.24% year-over-year

  • What is 3-year change in NVAX annual cash from financing?

    NVAX annual cash from financing is down -43.56% over the past 3 years

  • How far is NVAX annual cash from financing from its all-time high?

    NVAX annual cash from financing is currently -73.54% below its historical high of $984.76M set on December 31, 2020

  • How does NVAX annual cash from financing rank versus sector peers?

    NVAX annual cash from financing is higher than 92.36% of companies in Healthcare sector

  • When is NVAX next annual earnings release?

    The next annual earnings release for NVAX is on

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. NVAX Official Website www.novavax.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1000694/000100069425000046/0001000694-25-000046-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000694/000100069425000004/0001000694-25-000004-index.htm
  4. NVAX Profile on Yahoo Finance finance.yahoo.com/quote/NVAX
  5. NVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvax